The use of low-dose colchicine to prevent flares on initiation of urate-lowering therapy is cost effective in Australia if not the US, a rheumatologist has told the 2019 APLAR-ARA meeting in Brisbane. Dr Phil Robinson of the Royal Brisbane and Women’s Hospital and University of Queensland said that guidelines recommended the use of flare prophylaxis because it was ...
Colchicine prophylaxis of gout flares proves to be good value
By Mardi Chapman
11 Apr 2019